Navigation Links
Number of Patients Treated with an Antibiotic for MRSA Within U.S. Acute Care Hospitals Increased 8 Percent from 2006 to 2007
Date:6/25/2008

However, the Average Number of Days of Inpatient Therapy per Patient Treated with an Antibiotic for MRSA Decreased by 10 Percent, According to

New Data Released by Arlington Medical Resources

MALVERN, Penn., June 25 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the number of patients treated with an antibiotic associated with a positive culture for MRSA within U.S. acute care hospitals has increased from 2006 to 2007 by 8 percent. However, the average number of days of inpatient therapy per patient treated with an antibiotic associated with a positive culture for MRSA decreased by 10 percent.

The newly released edition of The U.S. Hospital Antibiotic Market Guide finds that the most common infections among these patients with a positive culture for MRSA are:

-- Skin/skin structure infections (46 percent of patients)

-- Systemic infections (19 percent of patients)

-- Lower respiratory infections (19 percent of patients)

Why Pharmaceutical Companies Need this Information

The U.S. Hospital Antibiotic Market Guide allows pharmaceutical companies to quantify the clinical utilization of hospital antibiotics at a highly granular level in the United States. It is the most comprehensive data available to gain insights into clinical usage and prescriber dynamics of hospital antibiotics, including gram positive and gram negative agents.

"With a large pipeline of late-stage anti-MRSA products, biopharmaceutical companies are demanding accurate information on MRSA usage patterns and trends so they can understand the current market and how treatments will evolve with the launch of new anti-MRSA drugs," said Joyce Wedemeyer, product director at AMR. "The U.S. Hospital Antibiotic Market Guide allows marketing, new product planning, market research and marketing teams to understand how antibiotic products are used in terms of combination therapy, types of infections, treatment intent and setting, and the types of specialists who are prescribing."

About U.S. Hospital Antibiotic Market Guide

The U.S. Hospital Antibiotic Market Guide is a semiannual syndicated clinical audit of antibacterial use in U.S. acute care hospitals. The audit is based on antibacterial census data from 250 demographically representative hospitals, plus a detailed clinical review of 11,000 randomly selected inpatient records yielding 25,000 antibiotic drug courses each 6-month audit cycle. The Hospital Antibiotic Market Guide is also available for France, Germany, Italy, Spain and the United Kingdom.

About AMR

AMR (http://www.AMR-data.com) is a pharmaceutical market research firm serving the market intelligence needs of the pharmaceutical and diagnostic imaging industries since 1991. With offices in Malvern, PA and Brussels and affiliates in Tokyo, Seoul and Shanghai, AMR publishes syndicated audits for the United States, Italy, Germany, United Kingdom, France, Spain, China, Japan and Korea. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ASCO Results: Oncologists Rank Genentech Number One
2. Nikon Instruments Receives Record Number of Entries for Nikon Small World
3. Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada
4. Nanotubes grown straight in large numbers
5. BioSpace Career Fair in San Diego Draws Record Number of Bioscience Candidates
6. The neural basis of number sense in young infants
7. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
8. New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
9. Sensitivity Enhancements to Monograms Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
10. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
11. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... At its national board meeting in North ... the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology and ... ARCS Alumni Hall of Fame . ASTER Labs is a technology development ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... BALTIMORE, Md. (PRWEB) , ... October 11, 2017 ... ... for digital pathology, announced today it will be hosting a Webinar titled, “Pathology ... of  Advanced Pathology Associates , on digital pathology adoption best practices and how ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
Breaking Biology Technology:
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
Breaking Biology News(10 mins):